1 week Ago By ABMN Staff
Raymond James Financial Inc. acquired a new position in shares of VanEck Biotech ETF ( NASDAQ:BBH – Free Report ) in the 4th quarter, HoldingsChannel reports. The fund acquired 21,540 shares of the company’s stock, valued at approximately $3,381,000.
Several other hedge funds also recently modified their holdings of the stock. Strategic Financial Concepts LLC acquired a new stake in VanEck Biotech ETF in the fourth quarter valued at approximately $3,828,000. Atlas Capital Advisors Inc.
acquired a new stake in VanEck Biotech ETF in the 4th quarter valued at $895,000. Tocqueville Asset Management L.P.
acquired a new stake in VanEck Biotech ETF in the 4th quarter valued at $860,000. Wells Fargo & Company MN increased its stake in VanEck Biotech ETF by 5.7% during the 4th quarter.
Wells Fargo & Company MN now owns 75,826 shares of the company’s stock valued at $11,902,000 after purchasing an additional 4,064 shares in the last quarter. Finally, Janney Montgomery Scott LLC acquired a new position in VanEck Biotech ETF during the fourth quarter worth $481,000. Institutional investors own 32.
05% of the company’s stock. VanEck Biotech ETF Price Performance Shares of NASDAQ BBH opened at $149.00 on Monday.
VanEck Biotech ETF has a 1 year low of $135.34 and a 1 year high of $183.64.
The stock has a market capitalization of $341.21 million, a P/E ratio of 31.41 and a beta of 0.
82. The company has a 50-day moving average price of $156.03 and a 200-day moving average price of $161.
87. About VanEck Biotech ETF The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Further Reading Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Biotech ETF ( NASDAQ:BBH – Free Report ). Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.
com's FREE daily email newsletter ..
